Comparative Pharmacology
Head-to-head clinical analysis: FREAMINE III 8 5 versus FREAMINE III 8 5 W ELECTROLYTES.
Peer-Reviewed Evidence
Head-to-head clinical analysis: FREAMINE III 8 5 versus FREAMINE III 8 5 W ELECTROLYTES.
FREAMINE III 8.5% vs FREAMINE III 8.5% W/ ELECTROLYTES
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
FREAMINE III 8.5% is a crystalline amino acid solution that provides essential and non-essential amino acids for protein synthesis, nitrogen balance maintenance, and tissue repair. It acts as a substrate for protein anabolism in patients unable to tolerate adequate oral or enteral intake.
FREAMINE III 8.5% W/ ELECTROLYTES is a crystalline amino acid solution that provides essential and non-essential amino acids for protein synthesis, promoting nitrogen balance and tissue maintenance in patients unable to tolerate oral/enteral nutrition.
Intravenous infusion; typical adult dose is 0.8-1.5 g amino acids/kg/day (equivalent to 9.4-17.6 mL/kg/day of Freamine III 8.5%). Initiate at lower end and titrate to metabolic needs. Administer via central or peripheral line with dextrose and electrolytes as part of parenteral nutrition.
Intravenous infusion: 1.0-1.5 g amino acids/kg/day (equivalent to 12-18 mL/kg/day of 8.5% solution). Administer via central or peripheral line. Typical adult dose: 500-1000 mL/day infused at 125-200 mL/hour.
None Documented
None Documented
Terminal elimination half-life of infused amino acids is approximately 15-30 minutes for most, but albumin synthesis half-life is 20-22 days; clinical context: continuous infusion needed for nitrogen balance.
Not applicable as a composite mixture; individual amino acid half-lives vary from minutes to hours. Clinical context: continuous infusion used for metabolic support.
Renal: 90-95% of infused amino acids are reabsorbed; excess nitrogen excreted as urea (80-90% of nitrogen load) and ammonia (<10%). Biliary/fecal: negligible (<5%).
Renal (primarily as urea and ammonia); 100% of infused amino acids are metabolized or excreted renally. Fecal excretion negligible.
Category C
Category C
Parenteral nutrition amino acid
Parenteral nutrition amino acid